Is VERA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VERA. It does not provide personalized investment advice.

VERA (Vera Therapeutics, Inc. Class A Common Stock) Stock Analysis - Financials

Vera Therapeutics, Inc. Class A Common Stock (VERA) is a publicly traded Healthcare sector company. As of September 15, 2026, VERA trades at $39.03 with a market cap of $2.53B and a P/E ratio of -7.30. VERA moved +14.61% today. Year to date, VERA is -32.76%; over the trailing twelve months it is +43.25%. Its 52-week range spans $18.53 to $56.05. Analyst consensus is strong buy with an average price target of $76.75. Rallies surfaces VERA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are VERA's key financials?

VERA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VERA recently traded at $39.03. Market cap is $2.53B. P/E ratio is -7.30. Revenue is $0.

VERA Key Metrics

Key financial metrics for VERA
Metric	Value
Price	$39.03
Market Cap	$2.53B
P/E Ratio	-7.30
EPS	$-4.66
Dividend Yield	0.00%
52-Week High	$56.05
52-Week Low	$18.53
Volume	696.57K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-299.62M
Gross Margin	0.00%

VERA Analyst Consensus

12 analysts cover VERA: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $76.75.

Common questions about VERA

What are VERA's key financials?: VERA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VERA recently traded at $39.03. Market cap is $2.53B. P/E ratio is -7.30. Revenue is $0.
Is VERA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VERA. It does not provide personalized investment advice.